Search research articles
Contact Us
Filters
Showing results (181-190 of 357) with videos related to
Page
of 36
Sort By:
The Journal of Allergy and Clinical Immunology
|
October 15, 2008
Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency
Sung-Yun Pai, Ofer Levy, Haifa H Jabara, et al.
The Journal of Allergy and Clinical Immunology
|
January 9, 2008
IKBKG (nuclear factor-kappa B essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function
Bryn H Salt, Julie E Niemela, Rahul Pandey, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
July 22, 2019
The role of breast-feeding in cytomegalovirus transmission and hematopoietic stem cell transplant outcomes in infants with severe combined immunodeficiency
William J Kelty, Shona A Beatty, Shuya Wu, et al.
Blood
|
November 30, 2011
Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity
Keri B Sanborn, Emily M Mace, Gregory D Rak, et al.
Molecular Biology of the Cell
|
October 4, 2013
Arf-like GTPase Arl8b regulates lytic granule polarization and natural killer cell-mediated cytotoxicity
Amit Tuli, Jerome Thiery, Ashley M James, et al.
Plos One
|
September 19, 2018
CLEC16A regulates splenocyte and NK cell function in part through MEK signaling
Rahul Pandey, Marina Bakay, Heather S Hain, et al.
Pediatrics
|
January 9, 2013
Severe combined immunodeficiency resulting from mutations in MTHFD1
Michael D Keller, Jaya Ganesh, Meredith Heltzer, et al.
Clinical Immunology (Orlando, Fla.)
|
February 25, 2017
Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome
Soma Jyonouchi, Brenda Gwafila, Lavesh A Gwalani, et al.
Clinical and Experimental Immunology
|
July 11, 2012
Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy
J S Orange, B H Belohradsky, M Berger, et al.
Mediators of Inflammation
|
March 24, 2016
HIV Progression Perturbs the Balance of the Cell-Mediated and Anti-Inflammatory Adaptive and Innate Mycobacterial Immune Response
Andrew R DiNardo, Anna M Mandalakas, Gugu Maphalala, et al.
Page
of 36
Search research articles
Search
Showing results (181-190 of 357) with videos related to
Sort By:
Page
of 36
The Journal of Allergy and Clinical Immunology
|
October 15, 2008
Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency
Sung-Yun Pai, Ofer Levy, Haifa H Jabara, et al.
The Journal of Allergy and Clinical Immunology
|
January 9, 2008
IKBKG (nuclear factor-kappa B essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function
Bryn H Salt, Julie E Niemela, Rahul Pandey, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
July 22, 2019
The role of breast-feeding in cytomegalovirus transmission and hematopoietic stem cell transplant outcomes in infants with severe combined immunodeficiency
William J Kelty, Shona A Beatty, Shuya Wu, et al.
Blood
|
November 30, 2011
Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity
Keri B Sanborn, Emily M Mace, Gregory D Rak, et al.
Molecular Biology of the Cell
|
October 4, 2013
Arf-like GTPase Arl8b regulates lytic granule polarization and natural killer cell-mediated cytotoxicity
Amit Tuli, Jerome Thiery, Ashley M James, et al.
Plos One
|
September 19, 2018
CLEC16A regulates splenocyte and NK cell function in part through MEK signaling
Rahul Pandey, Marina Bakay, Heather S Hain, et al.
Pediatrics
|
January 9, 2013
Severe combined immunodeficiency resulting from mutations in MTHFD1
Michael D Keller, Jaya Ganesh, Meredith Heltzer, et al.
Clinical Immunology (Orlando, Fla.)
|
February 25, 2017
Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome
Soma Jyonouchi, Brenda Gwafila, Lavesh A Gwalani, et al.
Clinical and Experimental Immunology
|
July 11, 2012
Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy
J S Orange, B H Belohradsky, M Berger, et al.
Mediators of Inflammation
|
March 24, 2016
HIV Progression Perturbs the Balance of the Cell-Mediated and Anti-Inflammatory Adaptive and Innate Mycobacterial Immune Response
Andrew R DiNardo, Anna M Mandalakas, Gugu Maphalala, et al.
Page
of 36